Go Back   SEQanswers > Sequencing Technologies/Companies > Vendor Forum

Similar Threads
Thread Thread Starter Forum Replies Last Post
Target Sequence Enrichment 454 dottomarco 454 Pyrosequencing 12 06-20-2012 07:40 AM
Agilent SureSelect: problems with target enrichment Asereth SOLiD 6 06-05-2012 11:37 PM
SureSelect target enrichment. Optimal hybridization time Staph Sample Prep / Library Generation 8 02-15-2012 05:07 AM
Enrichment with AGILENT's Sureselect target enrichment system dottomarco 454 Pyrosequencing 1 11-18-2009 02:14 AM
Roche/454 Titanium Amplicon sequencing? robhall Sample Prep / Library Generation 7 09-01-2009 10:58 AM

Thread Tools
Old 12-15-2010, 03:03 PM   #1
Junior Member
Location: Santa Clara, California

Join Date: Nov 2010
Posts: 3
Default SureSelect Target Enrichment Now Available for Roche 454 Sequencing!

TRADE NEWS: Agilent Technologies’ Target Enrichment System Now Supports 454 Life Sciences Next-Generation Sequencing Platform

SANTA CLARA, Calif., Dec. 15, 2010 -- Agilent Technologies Inc. (NYSE: A) today announced that its SureSelect Target Enrichment System now supports the 454 Life Sciences next-generation sequencing platform, boosting efficiency and cost-effectiveness of research by enabling users to sequence just genomic regions of interest rather than entire genomes.

“The SureSelect Target Enrichment Kits are now optimized and validated for all three major next-gen sequencing platforms,” said Fred P. Ernani, Ph.D., Agilent SureSelect platform business manager. “This should drive continued rapid adoption of our target enrichment system by the life sciences community. Accordingly, we will continue to aggressively develop new SureSelect products to help customers address a wider range of important scientific challenges.”

In addition to the 454, Agilent SureSelect Target Enrichment is fully compatible with the Illumina Genome Analyzer and HiSeq platforms, and Life Technologies’ SOLiD sequencers. The SureSelect kits have been cited in 25 publications this year, covering research into a wide range of heritable disorders.

The SureSelect portfolio includes target enrichment for user-specified genomic regions, human kinome, human X chromosome and human all exon sequencing.

Agilent’s SureSelect Target Enrichment portfolio offers the industry’s broadest range of target enrichment products and the most highly optimized protocols for a diverse set of sequencing methods and platforms. SureSelect products are available for enrichment of target sizes ranging from smaller than 200 Kb to more than 50 Mb in a single tube.

SureSelect Target Enrichment Kits are easily designed to target any genomic region of interest using Agilent’s eArray design tool, available in desktop or on-line versions.

For more information, visit Find eArray at

About Agilent Technologies
Agilent Technologies Inc. (NYSE: A) is the world’s premier measurement company and a technology leader in chemical analysis, life sciences, electronics and communications. The company’s 18,500 employees serve customers in more than 100 countries. Agilent had net revenues of $5.4 billion in fiscal 2010. Information about Agilent is available at

Stuart Matlow
+1 553 7191
Attached Files
File Type: pdf 5990-7087ENSureSelect_454_PRODUCT_Flyer.pdf (679.0 KB, 16 views)
File Type: pdf SureSelect_454_PROMO_Flyer.pdf (423.0 KB, 14 views)
SureSelectGuru is offline   Reply With Quote
Old 12-15-2010, 03:07 PM   #2
--Site Admin--
Location: SF Bay Area, CA, USA

Join Date: Oct 2007
Posts: 1,358

Moving overtly commercial content to Vendor Forum
ECO is offline   Reply With Quote

Thread Tools

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off

All times are GMT -8. The time now is 01:43 AM.

Powered by vBulletin® Version 3.8.9
Copyright ©2000 - 2020, vBulletin Solutions, Inc.
Single Sign On provided by vBSSO